Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05868174
Title Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Telix Pharmaceuticals (Innovations) Pty Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Macquarie University RECRUITING North Ryde New South Wales Australia Details
Ashford (Icon) Cancer Centre RECRUITING Adelaide Australia Details
Princess Alexandra Hospital RECRUITING Brisbane Australia Details
Austin Health RECRUITING Melbourne Australia Details
GenesisCare Murdoch RECRUITING Perth Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field